ZELLKULTURVERFAHREN

European patent · EP3717631 · In force

Register entry

Publication number
EP3717631
Application number
EP18811257
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 29, 2018
Published
Oct 7, 2020
Granted
Aug 30, 2023
Protection ends at the latest
Nov 28, 2038
Next annual fee due
Nov 30, 2026
IPC classes
C12N 5/00 (2006.01)
Priority
EP 17204978 01.12.2017
PCT application
PCT/EP2018/083010 29.11.2018
PCT publication
WO2019/106091 06.06.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Jun 12, 2024

    Change

    Published in Swissreg on 12.06.2024

  4. Jun 12, 2024

    Change

    Published in Swissreg on 12.06.2024

  5. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  6. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  7. Aug 30, 2023

    Granted

    Published in Swissreg on 30.08.2023

Parties

Holder

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventor

MALPHETTES, Laetitia

1070 Brussels, BE

CHEVALLIER, Valentine

1070 Brussels, BE

KOCHANOWSKI, Nadine

1070 Brussels, BE

COOL, Vincent Adolphe Carol

1070 Brussels, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.